EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS.

NCT04743453 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

211

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation
Diabetes Mellitus, Type 2
Diabetes Complications

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

University of Sao Paulo General Hospital

Collaborators

[object Object]